Stock listing

OTC:BIMI BIMI International Medical Inc Stock

Follow BIMI International Medical Inc into a list and get an email when it puts out news.

Share price · OTC:BIMI

$0.0004 USD 0.0000 (0.0%)

Close on Nov 18, 2026

Past year +300.0% · daily closes, Nov 19, 2025 – Nov 18, 2026, adjusted for splits
Day range
$0.0004 – $0.0004 USDNov 18, 2026
Volume
3 sharesNov 18, 2026
Market cap
$5,584 USDAt the close on Nov 18, 2026 · price × 13.96M shares outstanding
52-week range
$0.0001 – $0.0005 USDLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
BIMI International Medical Inc logo

Daily closes

Last 3 months, Aug 19, 2026 – Nov 18, 2026 · OTC:BIMI · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00040.00000.0%$0.0004$0.0004$0.00043
$0.00040.00000.0%$0.0004$0.0004$0.0004100
$0.0004-0.0001-20.0%$0.0004$0.0004$0.0004100
$0.0005+0.0004+400.0%$0.0005$0.0005$0.00053,000
$0.0001-0.0001-50.0%$0.0001$0.0001$0.000110,005
$0.0002-0.0003-60.0%$0.0002$0.0002$0.00022,051
$0.0005+0.0004+400.0%$0.0005$0.0005$0.00051,562
$0.00010.00000.0%$0.0001$0.0001$0.0001440
$0.00010.00000.0%$0.0001$0.0001$0.0001159
$0.00010.00000.0%$0.0001$0.0001$0.0001253
$0.00010.00000.0%$0.0001$0.0001$0.00011,552
$0.00010.00000.0%$0.0001$0.0001$0.00013,584

Splits

5 splits since 2006 · OTC:BIMI · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
1-for-5Consolidation
2-for-5Consolidation
1-for-3Consolidation
1-for-35Consolidation
Ticker
OTC:BIMI
Asset type
Stock
Exchange
OTC
Currency
USD

Events

QuarterResults
Q3 2023Dec 29, 2023 · After close
Q2 2023Aug 22, 2023
Q1 2023May 22, 2023 · Before open
Q3 2022Nov 21, 2022 · After close
Q2 2022Aug 22, 2022 · After close
Q1 2022Apr 18, 2022
Q3 2021Nov 15, 2021
Q2 2021Aug 16, 2021
Q1 2021Apr 1, 2021
Q4 2020Mar 31, 2021

Open Events

Financials

Annual, in USD

Income statement

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue12.6M11.8M21.3M12.8M158.0K6.54M8.51M6.04M6.71M9.98M
Cost of revenue7.54M9.88M18.9M10.4M304.1K6.08M7.59M5.89M5.54M8.50M
Gross profit5.09M1.95M2.43M2.44M-146.0K459.4K916.5K148.8K1.18M1.48M
Research and development56.2K73.2K96.6K105.2K107.9K
Selling, general and administrative8.91M10.6M6.06M5.47M986.0K16.1M2.05M1.59M1.72M1.83M
Operating income-3.82M-15.3M-8.11M-3.81M-986.0K-15.8M-1.20M-1.48M-641.0K-376.0K
Depreciation and amortization248.7K223.6K244.1K56.0K262.0K1.04M944.0K998.2K1.27M844.7K
EBITDA-3.57M-15.1M-7.86M-3.76M-724.0K-14.8M-251.0K-481.8K632.8K468.7K
Interest expense1.09M3.43M2.44M84.9K6.35K416.4K353.7K354.4K398.6K420.9K
Income before tax-10.6M-21.6M-34.7M-3.35M-1.54M-17.0M-1.58M-1.82M-1.01M-552.0K
Income tax6.09K29.7K434.3K1171172.74K246-40.3K64.9K
Net income-10.5M-22.4M-35.0M-5.29M-4.44M-16.8M-1.57M-1.82M-969.0K-617.0K
Earnings per share, basic-8.40-65.24-24.80-27.17-2.22-11.10-13.82-7.73-5.44

Balance sheet

LineFY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash and equivalents2.34M4.80M135.3K36.4K17.9K282.2K124.6K434.6K1.30M
Receivables4.18M6.07M8.34M10.1K1.34M16.4M7.27M8.27M9.10M
Inventory7.65M5.15M735.4K707.5K938.0K2.06M4.61M7.05M5.62M
Current assets23.2M21.2M25.2M22.0M2.61M18.8M15.1M19.6M18.8M
Property, plant and equipment8.37M910.2K38.6K18.0M20.0M19.6M22.0M26.4M
Goodwill2.07M8.38M6.91M0
Total assets35.7M38.1M33.2M30.1M23.1M41.4M37.3M44.4M48.3M
Accounts payable10.8M5.20M5.85M3.20M7.25M3.98M3.40M4.88M5.81M
Current liabilities25.4M22.1M15.6M21.5M13.1M14.1M10.6M14.0M17.0M
Long-term debt314.8K538.0K721.0K
Total debt5.46M8.73M5.03M107.4K5.82M7.22M5.76M8.06M9.95M
Total liabilities30.5M26.8M16.3M21.5M13.1M14.1M10.6M14.0M17.0M
Shareholders' equity4.05M11.2M16.7M8.68M9.99M27.2M26.7M30.4M31.3M
Shares outstanding2.67M536.3K213.5K163.4K7.57M141.5K131.5K125.3K113.4K

Cash flow

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations-2.90M-10.3M-1.28M-3.52M-2.06M-344.0K-908.2K159.8K-2.47M-995.1K
Capital spending00-814.7K-259.0K-259.0K-259.0K-259.0K-407.5K-663.3K-341.6K
Free cash flow-3.50M-10.3M-2.09M-3.78M-2.06M-344.0K-908.2K-247.7K-3.14M-1.34M
Cash from investing-536.9K-696.5K-724.5K166.7K166.7K166.7K-407.5K1.59M-341.6K
Cash from financing3.14M8.43M6.88M3.99M1.84M211.3K1.05M-45.2K48.3K1.63M
Share buybacks3.09M500.0K16.5K
Change in cash-6.21K-2.27M4.66M133.7K36.7K-84.8K157.5K-309.9K-869.6K283.4K

Open Financials

Cap table

Built by 6ix from BIMI International Medical Inc’s releases

Common shares
13,960,740
Fully diluted
13,960,740

Fully diluted

LineShares
Common shares13,960,740

Share count over time

CountShares
Nov 22, 202613,960,740

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Fnu Oudom
Other companies: FCCC, Inc. (Chairman and President, Director · Apr 26, 2021 – Apr 26, 2021 · Past)
Director · May 9, 2022 – Jun 19, 2023 · Past
Baiqun ZhongCFO · May 21, 2021 – May 21, 2021 · Past
Sammi Ean Seok AngDirector · May 12, 2022 – May 12, 2022 · Past

Open People

Log in to ask 6ix AI your own questions about BIMI International Medical Inc.